» Articles » PMID: 32961915

A Statistical Analysis of Risk Factors and Biological Behavior in Canine Mammary Tumors: A Multicenter Study

Overview
Journal Animals (Basel)
Date 2020 Sep 23
PMID 32961915
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Canine mammary tumors (CMTs) represent a serious issue in worldwide veterinary practice and several risk factors are variably implicated in the biology of CMTs. The present study examines the relationship between risk factors and histological diagnosis of a large CMT dataset from three academic institutions by classical statistical analysis and supervised machine learning methods. Epidemiological, clinical, and histopathological data of 1866 CMTs were included. Dogs with malignant tumors were significantly older than dogs with benign tumors (9.6 versus 8.7 years, < 0.001). Malignant tumors were significantly larger than benign counterparts (2.69 versus 1.7 cm, < 0.001). Interestingly, 18% of malignant tumors were smaller than 1 cm in diameter, providing compelling evidence that the size of the tumor should be reconsidered during the assessment of the TNM-WHO clinical staging. The application of the logistic regression and the machine learning model identified the age and the tumor's size as the best predictors with an overall diagnostic accuracy of 0.63, suggesting that these risk factors are sufficient but not exhaustive indicators of the malignancy of CMTs. This multicenter study increases the general knowledge of the main epidemiologica-clinical risk factors involved in the onset of CMTs and paves the way for further investigations of these factors in association with CMTs and in the application of machine learning technology.

Citing Articles

Let-7b, miR-29b, and miR-125b as Potential Biomarkers for Differentiating Canine Mammary Carcinoma Histological Types.

Ferreira T, Dias F, Alves A, Gama A, Mano J, Oliveira P Animals (Basel). 2025; 15(1.

PMID: 39794962 PMC: 11718878. DOI: 10.3390/ani15010020.


Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges.

Bhutta Z, Choi K Arch Pharm Res. 2025; 48(1):43-61.

PMID: 39752109 DOI: 10.1007/s12272-024-01524-y.


Epidemiological investigation and surgical treatment of canine mammary tumors in Dalian, China, from 2019 to 2023.

Jing Z, Feng J, Jin H PLoS One. 2024; 19(11):e0314292.

PMID: 39576831 PMC: 11584073. DOI: 10.1371/journal.pone.0314292.


Proteomic analysis of extracellular vesicles derived from canine mammary tumour cell lines identifies protein signatures specific for disease state.

Gutierrez-Riquelme T, Karkossa I, Schubert K, Liebscher G, Packeiser E, Nolte I BMC Vet Res. 2024; 20(1):488.

PMID: 39462388 PMC: 11515202. DOI: 10.1186/s12917-024-04331-1.


Effect of neutering timing in relation to puberty on health in the female dog-a scoping review.

Moxon R, England G, Payne R, Corr S, Freeman S PLoS One. 2024; 19(10):e0311779.

PMID: 39401232 PMC: 11472935. DOI: 10.1371/journal.pone.0311779.


References
1.
Sorenmo K, Kristiansen V, Cofone M, Shofer F, Breen A, Langeland M . Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet Comp Oncol. 2009; 7(3):162-72. DOI: 10.1111/j.1476-5829.2009.00184.x. View

2.
Chang S, Chang C, Chang T, Wong M . Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002). J Am Vet Med Assoc. 2005; 227(10):1625-9. DOI: 10.2460/javma.2005.227.1625. View

3.
Rivera P, Melin M, Biagi T, Fall T, Haggstrom J, Lindblad-Toh K . Mammary tumor development in dogs is associated with BRCA1 and BRCA2. Cancer Res. 2009; 69(22):8770-4. DOI: 10.1158/0008-5472.CAN-09-1725. View

4.
Philibert J, Snyder P, Glickman N, Glickman L, Knapp D, Waters D . Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med. 2003; 17(1):102-6. DOI: 10.1892/0891-6640(2003)017<0102:iohfos>2.3.co;2. View

5.
Burrai G, Tanca A, De Miglio M, Abbondio M, Pisanu S, Polinas M . Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?. Tumour Biol. 2015; 36(11):9083-91. DOI: 10.1007/s13277-015-3661-2. View